Text and Data Mining valid from 2018-04-12
Received: 12 January 2018
Accepted: 4 April 2018
First Online: 12 April 2018
Ethics approval and consent to participate
: Not applicable.
: PA, TB, PB, DR, DE, RB, and SE declare that they have no competing interests. MU is co-author on multiple trials of treatments for nsLBP some of which are included in this review. He has received multiple research grants from NIHR and ARUK as chief or co-investigator, he is an editor for NIHR journal series for which he receives a fee. MU and RF are directors and shareholders of Clinvivo Ltd., a University of Warwick spin-out company.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.